Pancreatic Cancer Research

ResearcherNational Institutes for Quantum Science and TechnologyActive in the last 2 years

Taku Inaniwa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2967-4004; OpenAlex author ID A5049562896. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

  1. Comparison of supine and upright postures in carbon ion radiotherapy for pancreatic cancer: An in silico planning study. First author DOI 10.1002/mp.70325↗
  2. In Silico Study of Simultaneous Integrated Boost Carbon-Ion Radiotherapy for Locally Advanced Pancreatic Cancer. Last author DOI 10.1016/j.ijpt.2024.100585↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Makoto Shinoto · 2 shared papers, 2024–2026 · strength 0.57
  2. Taku Nakaji · 1 shared paper, 2024 · strength 0.31
  3. Shigeru Yamada · 1 shared paper, 2024 · strength 0.31
  4. Tetsuro Isozaki · 1 shared paper, 2026 · strength 0.26
  5. Yusuke Nomura · 1 shared paper, 2026 · strength 0.26
  6. Masahiro Jinzaki · 1 shared paper, 2026 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.